Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Brain Neoplasms × cemiplimab × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 23 Melanoma 16 Neoplasm Metastasis 11 Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Recurrence 8 Skin Neoplasms 6 Ovarian Neoplasms 5 Carcinoma, Squamous Cell 5 Head and Neck Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Basal Cell 4 Triple Negative Breast Neoplasms 3 Multiple Myeloma 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Glioblastoma 2 Cutaneous Squamous Cell Carcinoma 2 Colonic Neoplasms 2 Carcinoma, Large Cell 2 Carcinoma 2

Interventions

Temozolomide 25 Bevacizumab 13 Radiotherapy 11 Trastuzumab 10 Lomustine 9 Capecitabine 8 paclitaxel-Angiopep-2 conjugate 6 Radiation 5 Nivolumab 5 pembrolizumab 4 icotinib 4 dabrafenib 4 Lapatinib 4 Flucytosine 4 Dianhydrogalactitol 4 Corticotropin-Releasing Hormone 4 Chlorotoxin 4 vocimagene amiretrorepvec 3 tucatinib 3 osimertinib 3 motexafin gadolinium 3 abemaciclib 3 Surgical Procedures, Operative 3 Spermine Synthase 3 Radiosurgery 3 Paclitaxel 3 NVP-BKM120 3 Irinotecan 3 Gefitinib 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05317858 2025-12-10

LIMITLESS

InSightec

Phase 3 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡